Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy.
Cohen
C D
CD
Horster
S
S
Sander
C A
CA
Bogner
J R
JR
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D005260:Female; D019288:Herpesvirus 8, Human; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D012514:Sarcoma, Kaposi / Q000209:etiology* / Q000821:virology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D014421:Turkey
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab